Pregled bibliografske jedinice broj: 1269063
From recurrent intermediate bilateral uveitis to vision loss: macular edema case report
From recurrent intermediate bilateral uveitis to vision loss: macular edema case report // OSCON
Osijek, Hrvatska, 2023. str. 102-102 (poster, međunarodna recenzija, sažetak, znanstveni)
CROSBI ID: 1269063 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
From recurrent intermediate bilateral uveitis to
vision loss: macular edema case report
Autori
Pavlović, Vedrana ; Kolar, Kolar ; Dabić, Goran ; Lagator, Maja ; Kurevija, Valentina ; Perić, Leon, Melić Vuković, Marija
Vrsta, podvrsta i kategorija rada
Sažeci sa skupova, sažetak, znanstveni
ISBN
9789537736644
Skup
OSCON
Mjesto i datum
Osijek, Hrvatska, 30.03.2023. - 01.04.2023
Vrsta sudjelovanja
Poster
Vrsta recenzije
Međunarodna recenzija
Ključne riječi
macular edema, uveitis
Sažetak
Introduction: Inflammatory macular edema is characterized as intra-retinal or subretinal fluid accumulation in the macular region. It is the most common sight-threatening complication of uveitis that can potentially cause a permanent vision loss if it's not treated early on. Case report: We present a 29-year-old woman patient with sudden visual loss on both eyes. She was previously healthy without any history of genetic or ocular problems, also denying any toxic intake. Laboratory tests showed normal parametars. After the ophtamological exam was performed, it was revealed that she was suffering from bilateral intermediate uveitis (IU). The initial optical coherence tomograms (OCT) of the macula were normal. After the systemic workup and due to the autoimmune nature of uveitis - showed from HLA (Human Leukocyte Antigens) tissue typing results, both oral and local corticosteroids were started. After a month and a half of gradual tapering, her clinical status improved and her visual acuity returned to normal. After three months of quiescent phase, our patient had reccurence of bilateral IU as well as vision loss. Periocular injections of corticosteroids were introduced, but there was no response nor clinical improvement after 14-days treatment. Control OCT was required and revealed bilateral macular edema. Intravitreal application of triamcolone acetonide was applied in order to avoid permanent visual loss. This caused a rise of intraocular pressure that was corrected with antiglaucoma medications. OCT showed normal appereance of the macular region and the patient regained normal visual acuity. Conclusion: Due to complex workup and challenging diagnostic and therapeutic managment, upcoming data on pathogenesis, as well as new OCT devices, optimal algorithms and treatment strategies are neccesary for quality of life of uveitic patient
Izvorni jezik
Engleski
Znanstvena područja
Kliničke medicinske znanosti